# Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype

> **NCT05482854** · NA · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 50 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **OTHER:** Analytical Treatment Interruption (ATI)

## Key facts

- **NCT ID:** NCT05482854
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-20
- **Primary completion:** 2024-12
- **Final completion:** 2025-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05482854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05482854, "Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05482854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*